The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...

The global Personalized Testing & Supplements Market was valued at USD 13.6 billion in 2025 and is projected to grow from USD 15.7 billion in 2026 to USD 46.3 billion by 2033, registering a remarkable CAGR of 16.7% from 2026 to 2033. The market is experiencing rapid expansion as consumers increasingly seek personalized health solutions tailored to their unique genetics,...